secwatch.observer — SEC 8-K summary
======================================

Issuer:     STREAMLINE HEALTH SOLUTIONS INC. (—)
CIK:        0001008586
Form:       8-K
Filed at:   2024-04-29T23:59:59+00:00
Accession:  0001493152-24-017071
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 3.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Streamline Health Q4 rev $5.4M, net loss improves; Nasdaq extends bid price compliance to Oct 2024
--------------------------------------------------------------------------------

- Q4 FY2023 revenue $5.4M (down 19% YoY); net loss ($1.4M) vs ($2.2M) prior year; adjusted EBITDA $0.4M vs ($0.2M).
- Full-year FY2023 revenue $22.6M (down 9% YoY); net loss ($18.7M) including $10.8M impairment; adjusted EBITDA loss improved to ($1.4M) from ($3.8M).
- SaaS revenue grew $1.7M YoY; booked SaaS ACV $15.6M as of April 29, 2024, above adjusted EBITDA breakeven run rate of $15.5M.
- Nasdaq granted additional 180-day period until Oct 21, 2024 to regain minimum bid price of $1.00 per share.
- Bryant J. Reeves III appointed permanent CFO effective April 29, 2024; base salary increased to $225K; CEO Stilwill salary increased to $375K; both granted restricted stock.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1008586/000149315224017071/0001493152-24-017071-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1008586/000149315224017071/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-017071

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer